Abstract
The emergence of CDK4/6 inhibitors has changed the treatment algorithm for advanced/metastatic estrogen receptor-positive breast cancer. In pivotal tr......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
